Add-on Acquisition • Information Technology

Lunit Acquires Volpara Health

On December 14, 2023, Lunit acquired information technology company Volpara Health for 292M AUD

Acquisition Context
  • This is Lunit’s 1st transaction in the Information Technology sector.
  • This is Lunit’s largest (disclosed) transaction.
  • This is Lunit’s 1st transaction in New Zealand.

Explore All 9667 Add-on Acquisition Information Technology Deals - Search the Database Free


M&A Deal Summary

Date December 14, 2023
Target Volpara Health
Sector Information Technology
Buyer(s) Lunit
Deal Type Add-on Acquisition
Deal Value 292M AUD
Advisor(s) Minter Ellison (Legal)

Target Company

Volpara Health

Wellington, New Zealand
Volpara Health provides software to save families from cancer by helping healthcare providers positively impact communities around the world. The company is focused on understanding cancer risk, empowering patients in personal care decisions, improving and maintaining quality, and guiding recommendations about additional imaging, genetic testing, and other interventions. Its focus on customer value means that its AI-powered image analysis enables radiologists to quantify breast tissue with precision and helps technologists produce mammograms with optimal image quality. Volpara Health is based in Wellington, New Zealand.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Lunit

Seoul, South Korea

Category Company
Founded 2013
Sector Information Technology
Revenue 54.2B KRW (2024)
DESCRIPTION

Lunit is a deep learning-based medical AI company committed to harnessing AI to ensure accurate diagnosis and optimal treatment for each cancer patient using AI-powered medical image analytics and AI biomarkers. As a medical AI company grounded on clinical evidence, the company's findings are presented in major peer-reviewed journals, such as the Journal of Clinical Oncology and the Lancet Digital Health, and global conferences, including ASCO and RSNA. After receiving FDA clearance and the CE Mark, its flagship Lunit INSIGHT suite is clinically used in approximately 3,000+ hospitals and medical institutions across 40+ countries. Lunit was founded in 2013 and is based in Seoul, South Korea.


Deal Context for Buyer #
Overall 1 of 1
Sector: Information Technology 1 of 1
Type: Add-on Acquisition 1 of 1
Country: New Zealand 1 of 1
Year: 2023 1 of 1
Size (of disclosed) 1 of 1